Header cover image

Hong Kong (HSI) Life Sciences Industry Analysis

UpdatedJul 15, 2025
DataAggregated Company Financials
Companies11
  • 7D7.5%
  • 3M30.4%
  • 1Y94.7%
  • YTD44.7%

Over the last 7 days, the Life Sciences industry has risen 7.5%, driven by gains from WuXi Biologics (Cayman) of 6.8%. This takes the industry's 12 month performance to a gain of 95%. Looking forward, earnings are forecast to grow by 33% annually.

Industry Valuation and Performance

Has the Hong Kong Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 15 Jul 2025HK$240.4bHK$37.3bHK$2.7b49.5x87.6x6.5x
Thu, 12 Jun 2025HK$229.6bHK$36.2bHK$2.6b29.6x88.1x6.3x
Sat, 10 May 2025HK$188.7bHK$35.7bHK$2.6b26x73.7x5.3x
Mon, 07 Apr 2025HK$207.7bHK$35.5bHK$2.5b28.4x81.7x5.9x
Wed, 05 Mar 2025HK$186.1bHK$35.8b-HK$1,057,881,585.1846.1x-175.9x5.2x
Fri, 31 Jan 2025HK$157.0bHK$36.0b-HK$1,059,490,952.1352.3x-148.2x4.4x
Sun, 29 Dec 2024HK$158.3bHK$35.6b-HK$1,057,434,619.5958.3x-149.7x4.4x
Tue, 26 Nov 2024HK$132.4bHK$35.9b-HK$1,057,923,585.6146.5x-125.2x3.7x
Thu, 24 Oct 2024HK$162.0bHK$35.7b-HK$660,780,589.7329x-245.2x4.5x
Sat, 21 Sep 2024HK$153.6bHK$36.0b-HK$655,634,364.3326.4x-234.3x4.3x
Mon, 19 Aug 2024HK$101.9bHK$35.0bHK$2.5b18x41x2.9x
Wed, 17 Jul 2024HK$92.9bHK$33.4bHK$3.1b19.7x30.2x2.8x
Fri, 14 Jun 2024HK$95.6bHK$33.5bHK$3.1b24.7x31x2.9x
Sun, 12 May 2024HK$114.5bHK$33.6bHK$3.1b29.5x37x3.4x
Tue, 09 Apr 2024HK$112.2bHK$33.6bHK$3.1b33x36.2x3.3x
Thu, 07 Mar 2024HK$155.5bHK$32.3bHK$3.0b65.1x52.3x4.8x
Sat, 03 Feb 2024HK$124.4bHK$32.6bHK$3.0b52.1x41.1x3.8x
Mon, 01 Jan 2024HK$212.8bHK$32.6bHK$3.0b90.4x70.3x6.5x
Wed, 29 Nov 2023HK$285.4bHK$32.3bHK$3.0b88.1x95.4x8.8x
Fri, 27 Oct 2023HK$238.5bHK$30.1bHK$2.7b42.6x89.6x7.9x
Sun, 24 Sep 2023HK$230.6bHK$30.1bHK$2.7b40.7x86.3x7.7x
Tue, 22 Aug 2023HK$216.6bHK$28.2bHK$2.7b23.5x80.5x7.7x
Thu, 20 Jul 2023HK$213.6bHK$28.3bHK$2.7b22.2x78.8x7.5x
Sat, 17 Jun 2023HK$251.8bHK$28.7bHK$2.8b22.8x90.6x8.8x
Mon, 15 May 2023HK$243.5bHK$29.3bHK$2.9b22x84.2x8.3x
Wed, 12 Apr 2023HK$258.3bHK$29.6bHK$3.0b17.3x86.4x8.7x
Fri, 10 Mar 2023HK$275.9bHK$26.1bHK$2.0b25.1x137.7x10.6x
Sun, 05 Feb 2023HK$347.5bHK$26.7bHK$2.1b29.6x162.2x13x
Tue, 03 Jan 2023HK$315.8bHK$26.2bHK$2.0b26.5x154.7x12.1x
Thu, 01 Dec 2022HK$262.6bHK$25.5bHK$1.9b26.3x140.8x10.3x
Sat, 29 Oct 2022HK$212.4bHK$25.4bHK$1.8b19.3x115.9x8.4x
Mon, 26 Sep 2022HK$242.9bHK$25.7bHK$1.9b21x128x9.4x
Wed, 24 Aug 2022HK$346.8bHK$25.2bHK$2.8b10.7x125.1x13.7x
Fri, 22 Jul 2022HK$419.4bHK$22.3bHK$2.0b12.9x206.1x18.8x
Price to Earnings Ratio

206.1x


Total Market Cap: HK$419.4bTotal Earnings: HK$2.0bTotal Revenue: HK$22.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Life Sciences Industry Price to Earnings3Y Average 29.2x202320242025
Current Industry PE
  • Investors are optimistic on the Hong Kong Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 87.6x which is higher than its 3-year average PE of 29.2x.
  • The industry is trading close to its 3-year average PS ratio of 7.1x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 10% per year over the last three years.
  • Revenues for these companies have grown 19% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Hong Kong Healthcare industry?

HK Market1.79%
Healthcare3.58%
Life Sciences7.54%
Clinical Research and Equipment7.54%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
2269 WuXi Biologics (Cayman)HK$26.756.8%
+HK$6.9b
141.4%PE29.6x
2268 WuXi XDC CaymanHK$48.1510.7%
+HK$5.6b
211.0%PE49.5x
2228 XtalPi HoldingsHK$5.798.2%
+HK$1.8b
-0.2%PS79.8x
1548 Genscript BiotechHK$15.183.7%
+HK$1.2b
21.1%PS7.1x
3880 MedtideHK$36.9517.3%
+HK$772.8m
n/aPE80.9x

Latest News